publication date: Jun. 28, 2019

MD Anderson submits “plan of correction” to fix care deficiencies after patient dies from infected transfusion 

By Matthew Bin Han Ong

Responding to removal of its Medicare “deemed status,” MD Anderson Cancer Center has submitted a “plan of correction” to the Texas Health and Human Services Commission to demonstrate that it is now in compliance with all federal requirements for participation in the Medicare program.

The 94-page plan, which includes a cover letter from MD Anderson President Peter Pisters, was publicly released by the Centers for Medicare and Medicaid Services June 24.

MD Anderson’s submission is available here.

Documents show that sanctions stem from a mishap where a patient, identified as “Patient #34,” died after receiving a blood transfusion at MD Anderson. Officials at the cancer center said that the case was reported to FDA in December 2018.

According to a summary report released by CMS, the transfusion was contaminated with bacteria. The patient, a 23 year-old woman with pre-B cell acute lymphoblastic leukemia, was admitted to receive a stem cell transplant.

The patient was receiving daily blood transfusions, documents show.

The transfusion of blood products from one human to another carries inherent risk, said Stephen Hahn, chief medical executive at MD Anderson.

“No matter how many safeguards are in place, these risks will always exist due to the nature of these procedures,” Hahn said to The Cancer Letter.

“For MD Anderson, the stakes are higher. We care for very sick patients with weakened immune system and, for these patients, the inherent risks of blood transfusions are higher and carry significant risks.

“While it is unfortunate that … Continue reading MD Anderson submits “plan of correction” to fix care deficiencies after patient dies from infected transfusion

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2019 The Cancer Letter Inc.